Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 24c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.46), $0.24 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $142 million versus the consensus estimate of $125.21 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Worthington Industries (WOR) Misses Q4 EPS by 9c